PULMONARY ARTERY STENTING AFfER TOTAL SURGICAL CORRECTION OF RIGHT VENTRICULAR OUTFLOW TRACT OBSTRUCTIVE LESIONS

Similar documents
NATIONAL INSTITUTE FOR CLINICAL EXCELLENCE PROGRAMME

Initial Experience Using the Palmaz Corinthian Stent for Right Ventricular Outflow Obstruction in Infants and Small Children

Intraoperative Stents to Rehabilitate Severely Stenotic Pulmonary Vessels

Isabella Spadoni, Sandra Giusti, Pietro Bertolaccini*, Alberto Maneschi*, Giuliano Kraft, Mario Carminati

For Personal Use. Copyright HMP 2013

Absent Pulmonary Valve Syndrome

Endovascular stents in children under 1

CONGENITAL HEART DEFECTS IN ADULTS

MRI (AND CT) FOR REPAIRED TETRALOGY OF FALLOT

INTERVENTIONAL PROCEDURES PROGRAMME

E xtracardiac conduits placed between the right ventricle

INTERVENTIONAL PROCEDURES PROGRAMME

Branch Pulmonary Artery Stenosis Long-term Outcomes of Endovascular Stenting

Appendix A.1: Tier 1 Surgical Procedure Terms and Definitions

Branch pulmonary artery stenosis accounts

Departments of Paediatrics and Cardiology, Mater Dei Hospital, Malta

IMAGES. in PAEDIATRIC CARDIOLOGY

Percutaneous Stent Placement in Children Weighing Less Than 10 Kilograms

Transcather Pulmonary Valve Replacement Using The Melody Valve: Indications, Techniques, Outcomes

Intravascular Stents in Congenital Heart Disease: Short- and Long-Term Results From a Large Single-Center Experience

Debanding and repair of ventricular septal defect: a new technique for older patients

The Chest X-ray for Cardiologists

Adult Congenital Heart Disease: What All Echocardiographers Should Know Sharon L. Roble, MD, FACC Echo Hawaii 2016

INTERVENTIONAL PROCEDURES PROGRAMME

Since their first use in patients with congenital heart disease

Stent implantation into the patent ductus arteriosus in cyanotic congenital heart disease with duct-dependent or diminished pulmonary circulation

가천의대길병원소아심장과최덕영 PA C IVS THE EVALUATION AND PRINCIPLES OF TREATMENT STRATEGY

TRANSCATHETER REPLACEMENT OF THE PULMONARY VALVE (PPVI)

Case Report. Stent Placement in a Neonate with Sano Modification of the Norwood using Semi-Elective Extracorporeal Membrane Oxygenation.

Debate: Should Ductal Stent Implantation be Considered for All Newborn Infants with Reduced Pulmonary Blood Flow?_Pros

Transcatheter Pulmonary Valve Replacement Update on progress and outcomes

Native Outflow Tract Transcatheter Pulmonary Valve Replacement

Congenital Heart Defects

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Cardiac Catheterization Cases Primary Cardiac Diagnoses Facility 12 month period from to PRIMARY DIAGNOSES (one per patient)

Adult Congenital Heart Disease T S U N ` A M I!

Cardiac MRI in ACHD What We. ACHD Patients

CMR for Congenital Heart Disease

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital

Case Report Computed Tomography Angiography Successfully Used to Diagnose Postoperative Systemic-Pulmonary Artery Shunt Narrowing

LEFT VENTRICULAR OUTFLOW OBSTRUCTION WITH A VSD: OPTIONS FOR SURGICAL MANAGEMENT

Congenital heart disease: When to act and what to do?

SURGICAL TREATMENT AND OUTCOME OF CONGENITAL HEART DISEASE

Implantation and Intermediate-Term Follow-up

Indications for the Brock operation in current

The Double Switch Using Bidirectional Glenn and Hemi-Mustard. Frank Hanley

NEONATAL HYBRID PROCEDURES STRATEGIES TO REDUCE MORBIDITY AND MORTALITY

S tent implantation to treat branch pulmonary artery. The efficacy and safety of stent redilatation in congenital heart disease

Original Policy Date

Early complications of stenting in patients with congenital heart disease: a multicentre study

S tent implantation to treat branch pulmonary artery

Common Defects With Expected Adult Survival:

A Novel Balloon Assisted Two-Stents Telescoping Technique for Repositioning an Embolized Stent in the Pulmonary Conduit

Aortography in Fallot's Tetralogy and Variants

The background of the Cardiac Sonographer Network News masthead is a diagnostic image:

Repair of very severe tricuspid regurgitation following detachment of the tricuspid valve

Outcomes Associated with the Off-label Use of Medical Devices in Congenital Heart Disease at a Single Institute

Journal of the American College of Cardiology Vol. 35, No. 4, by the American College of Cardiology ISSN /00/$20.

9/8/2009 < 1 1,2 3,4 5,6 7,8 9,10 11,12 13,14 15,16 17,18 > 18. Tetralogy of Fallot. Complex Congenital Heart Disease.

Low-dose prospective ECG-triggering dual-source CT angiography in infants and children with complex congenital heart disease: first experience

Balloon valvuloplasty and angioplasty in congenital

Adults with Congenital Heart Disease. Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP

Pediatric Echocardiography Examination Content Outline

Congenital Heart Disease An Approach for Simple and Complex Anomalies

Pediatric Cardiology. KEY WORDS: Balloon angioplasty--congenital heart disease

Cardiovascular MRI of Adult Congenital Heart Disease

Index. interventional.theclinics.com. Note: Page numbers of article titles are in boldface type.

Stenting in Congenital Heart Disease

Research Presentation June 23, Nimish Muni Resident Internal Medicine

In 1980, Bex and associates 1 first introduced the initial

Hemodynamic Assessment After Complete Repair of Pulmonary Atresia With Major Aortopulmonary Collaterals

Fallot Tetralogy Imaging Findings with MDCT, pre and postoperative findings

Adult Congenital Heart Disease: The New Reality. Disclosures

Reconstruction of right ventricular outflow with a valved homograft conduit

HISTORY. Question: What type of heart disease is suggested by this history? CHIEF COMPLAINT: Decreasing exercise tolerance.

Surgical Treatment for Double Outlet Right Ventricle. Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery

Chapter 13 Worksheet Code It

Hemodynamic assessment after palliative surgery

Systemic-Pulmonary Shunts in Neonates and Infants Using Microporous Expanded Polytetrduoroethylene: Immediate and Late Results

No Relationships to Disclose

Anatomy & Physiology

PATENT DUCTUS ARTERIOSUS (PDA)

Debate in Management of native COA; Balloon Versus Surgery

Assessing Cardiac Anatomy With Digital Subtraction Angiography

Surgical Procedures. Direct suture of small ASDs Patch repair Transcatheter closure with a prosthetic device called occluder

Echocardiography in Adult Congenital Heart Disease

Pulmonary Valve Replacement

Dates to which data relate The effectiveness and resource use data refer to the period 1983 to The price year was 1994.

A teenager with tetralogy of fallot becomes a soccer player

Cardiac CT in Infants with Congenital heart disease Sunrise Session. LaDonna Malone, MD May 17, 2018

Native Outflow Tract TranscatheterThe Heart Center Pulmonary Valve Replacement

Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease

CP STENT. Large Diameter, Balloon Expandable Stent

Coarctation of the aorta

MEDICAL SCIENCES Vol.I -Adult Congenital Heart Disease: A Challenging Population - Khalid Aly Sorour

A New Radiopaque Surgical Suture* Juro WADA, M.D. and Masahiro ENDO, M.D.

PEDIATRIC AND CONGENITAL HEART DISEASE. Pulmonary Artery Stents in the Recent Era: Immediate

IMAGES. in PAEDIATRIC CARDIOLOGY

5.8 Congenital Heart Disease

Transcription:

Articles 5 PULMONARY ARTERY STENTING AFfER TOTAL SURGICAL CORRECTION OF RIGHT VENTRICULAR OUTFLOW TRACT OBSTRUCTIVE LESIONS SAMEH ARAB, MD; ERIC ROSENTHAL, MD, MRCP; SHAKEEL QURESHI, MB, MRCP; MICHAEL TYNAN, MD, FRCP SllTgical correction has been the definitive therapy for right ventricular (RV) outflow obstructive lesions. Associated stenosis in pulmonary artery (PA) branches also requires surgery. Although these stenoses can be relieved by balloon dilatation, stent placement increases the success rate. In this study, we evaluate the results of stent implantation in residual P A stenosis after surgery. The study included to patients with previous surgery who required stenting of a PA or RV infundibulum or reballooning of an anery: 5 patients with tetralogy of Fallot, two with pulmonary atresia, one with pulmonary stenosis, one with truncus aneriosus, and one with a surgically patched ventricular septal defect and PA banding. The median age at implantation was 9.4 (range, 0.5 to 36) years and the mean bodyweight was 34.6 :t 21.2 kg. Twelve procedures were performed with 17 stents implanted. The stent was implanted eight times into the left, seven times into the right, and twice into the main PA or infundibulum. After stenting, there was a significant decrease in the RV pressure and trans-stenotic gradient and an increase in the vessel diameter. Two patients required surgery after stenting, one due to stent displacement into the right ventricle and the other for outflow tract reconstruction. Major complications included stent migration twice and failure to implant three stents. Our study demonstrates the efficacy and safety of stent implantation after surgical correction of pulmonary arterial lesions which negates the need for funher surgery for residual lesions. SURGICAL CORREcrION has been the definitive therapy for patients with tetralogy of Fallot. This entails the patch closure of the ventricular septal defect (VSD) and infundibulectomy, with or without pulmonary valvotomy. Associated stenotic lesions in the pulmonary artery (P A) branches may be found in tetralogy of Fallot, and surgical correction in such cases may be more complicated because of the involvement of the branch arteries. Surgery may also make the procedure more difficult and prolong From the Department of Cardiology (Dr. Arab), Alexandria University, Alexandria, Egypt, and Department of Pediatric Cardiology (Drs. Rosenthal, Qureshi, and Tynan), Guy's Hospital, London, UK. Address reprint requests and correspondence to Dr. Arab: Department of Cardiology, Alexandria University, P.O. Box 21111, Alexandria, Egypt. its time. These problems also apply to other defects which involve right ventricular outflow tract (RVOT) obstruction. Interventional catheter therapy has drastically changed the practice of cardiac catheterization and treatment of congenital heart diseases. Interventional catheter therapy has become an alternative or a supplement to surgical treatment.i For some lesions, surgery has become virtually obsolete.2 Conventional surgery or balloon dilatation for P A stenosis has been unsatisfactory in many patients) Although 50% of P A stenoses can be relieved by balloon dilatation, stent placement increases the success rate from 70% to 80%.2 In adult cardiology, stents have been used extensively to support vessel walls in coronary and peripheral arteries.4 Nowadays, stents have become an important adjunct Journal of the Saudi Heart Association, Vol. 9, No.1. 1997

6 ARAB ET AL in the management of children with congenital heart diseases.5 In our study, we evaluate the results of stent implantation as a therapeutic procedure for residual PA stenosis after surgical correction of RVOT obstructive lesions, including peripheral P A stenoses. Materials and Methods Between February 1993 and June 1995, 25 patients underwent stent implantation at the Pediatric Cardiology Department at Guy's Hospital, in London. In ten of these patients, surgical correction alone was not sufficient; stent implantation into a P A or right ventricular (RV) infundibulum or reballooning of an artery after surgery was required. There were 5 patients with tetralogy of Fallot (one with associated straddling tricuspid valve), 2 patients with pulmonary atresia and VSD, 1 patient with valvar and subvalvar pulmonary stenosis who had undergone surgical valvotomy and infundibulectomy before the era of balloon dilatation, 1 patient with a common arterial trunk and associated bilateral P A stenoses, and I patient with a VSD that was patched surgically, with placement of a band at the main P A. One patient with tetralogy of Fallot did not have a previous total correction but had a Pott's procedure instead (Table 1). The age at stent implantation ranged between 6 months to 36 years (median, 9.4 years; mean, 12.68 :t 10.87 years) and bodyweight ranged between 4.88 to 69 (mean, 34.57 :t 21.21) kg. There were 4 males and 6 females. The median time interval between surgical correction and stent implantation was 4.72 (range, 0.44 to 35.23) years. The indications for stent implantations were P A stenosis with effort intolerance in five cases (42%), stenosis at the site of a shunt in two (17%), RV failure in two (17%), RVOT aneurysm in one (8%), and severe cyanosis in one (8%) (Table 1). These patients represent a group in which total surgical correction could not be considered a final and definitive procedure. Patients in whom the stent was implanted before corrective surgery were excluded from the study. In one patient with pulmonary atresia, the stent was implanted before corrective surgery. However, this needed to be dilated one year after surgery. We did not exclude this case from the study because the surgical correction was insufficient to be considered as a final therapeutic measure. The technique of stent implantation in the P A has been described previously.3 We reviewed the catheter-derived pressures and the stenotic P A diameter, before and after stenting, as well as the diameters and types of balloons used for dilatation. A single procedure was sufficient in 7 patients (Table 2). Two patients required stenting twice. In one of them, the right P A was successfully stented, while attempts to stent the left P A were unsuccessful due to failure to pass the sheath through the stenotic artery. The artery was dilated by balloon without stent insertion. The left PA was successfully stented 3 months later. In another patient, both the right PA (2 stents) and the left P A (1 stent) were successfully implanted at first attempt. Due to rising RV pressure, the procedure was repeated 7 months later, with implantation of the third stent into the right P A and balloon dilatation of the left P A. Afterwards, there was no need for further stenting. In 4 patients, two stents were placed simultaneously in the same P A, and a third stent in one of them on a separate occasion. The number of stents implanted per patient was four in 1 patient, three stents in 1 patient, two stents in 2 patients, and a single stent in 6 patients (Table 2). On eight occasions, the stent was implanted into the left P A (Figures 1-3), seven times into the right PA, and twice into the main PA or RV infundibulum (Table 2). balloons were used on seven occasions, Olbert balloons on four occasions, premounted Figure I. Right ventricular angiography showing a narrow left pulmonary artery (before stenting). Journal oflhe Saudi Hean Association. Vol. 9. No. I. 1997

PULMONARY ARTERY STENTING 7 stent-balloon assembly (Johnson and Johnson) was used three times, and Crystal (Bait) was used once. The balloon diameter ranged between 7 to 18 (mean, 11.13 :t 3.16) mm. The stents used were I to 3 (mean, 2.54 :t 0.88) cm long (Table 2). Results The study included 10 patients who had undergone twelve procedures. Seventeen stents were implanted at fifteen sites (Table 2). Figure 2. Right ventricular angiography after stenting of the left pulmonary artery. Previous Management Two patients with tetralogy of Fallot had modified Blalock-Taussig shunts before total correction, one patient had total correction without previous palliation, one patient had Pott's and Waterson shunts followed by laser-assisted balloon dilatation for acquired pulmonary atresia, and one patient had modified Blalock-Taussig and Pott's shunts followed by laser-assisted balloon dilatation (Table 1). One child with pulmonary atresia had a left modified Blalock-Taussig shunt p~rformed in the first year of life, followed by radiofrequency pulmonary valvotomy at the age of 5 years. One year later, the right major aorto-pulmonary collateral arteries were unifocalized, and a stent was implanted into the left PA nine days later. The other child with pulmonary atresia was corrected surgically. In the patient with pulmonary stenosis who had surgical valvotomy and infundibulectomy in 1972, the stent was implanted into the left P A 21 years later because of residual stenosis in the left P A and decreased effort tolerance. The infant with common arterial trunk had surgical repair at the age of 2 weeks, with stent implantation at both left P A and right P A 5 months later. The left PA stent was redilated after 7 months, with placement of another stent in the right P A. One patient with a VSD had main P A banding at 47 days of age. The band was removed eight years later during surgical closure of the VSD. On follow-up, due to development of main P A stenosis, a stent was inserted 20 years after P A debanding. Management Poststenting In 2 patients, surgery was performed after stenting. In one patient with tetralogy of Fallot and RVOT aneurysm following total correction, the stent was displaced into the RV. Attempts to compress by snare were unsuccessful, and it was removed surgically 2 days postimplantation with repair of the stenotic left P A. In another child with pulmonary atresia, the RVOT was reconstructed surgically and the VSDclosed 2 months after stenting of the left P A. The left P A was then dilated by balloon II months later (Table 2). Figure 3. Stent in the left pulmonary artery after dilatation. Hemodynamic Changes The RV and aortic systolic pressures (AO), the systolic gradient (GR) across the stenotic vessel, the Journal of the Saudi Hean Association. Vol. 9. No.1. 1997

PULMONARY ARTERY STENTING 9 Complications Failure of the procedure or major complications were encountered during implantation of three of seventeen stents (17.65%) at fifteen sites. Two stent migrations occurred. One stent was displaced into a RVOT aneurysm, necessitating surgical removal and left PA repair 2 days later. In another patient, one of two stents implanted in the left P A was displaced proximally into the main P A across the right P A origin. This necessitated trimming of the kink in the left PA origin during corrective surgery one month later. Both stents were reballooned one year later. Table 2. Characteristics of stems and dilating bal/oons. Patient Site of Length No. Balloon Balloon implant of stent stents diameter type (cm) (mm) I LPA 3 I 8 2 LPA 3 2 12 3 RPA 3 I 12 4a* RPA 3 2 14 Olben 4b LPA 3 I 10 Olben 5 RVOT 3 I 10 6a* LPA 3 2 12 6b (LPA)+ - - (14)+ Olben 1 RPA 3 I 14 Olben 8 LPA 3 I 12 9a* RPA I 2 1 Palmaz LPA I I 1 Palmaz 9bt RPA I I 7-10 Palmaz- (LPA)+ - - 10 10 MPA 3 I 18 Crystal LPA -left pulmonary artery; RPA - right pulmonary artery; RVOT - right ventricular outflow tract; MPA - main pulmonary artery. On a third occasion, we failed to implant a stent into the left P A due to failure to pass the sheath through, although there was successful implantation of another into the right P A. The left P A was dilated by balloon, and three months later it was successfully stented. Two minor complications should be mentioned. Transient hypotension occurred once, with the catheters across both P A. On one occasion, the balloon (7 mm) ruptured while implanting a third stent into the right P A between two previously implanted ones. The stent was partially expanded, necessitating dilatation by two other balloons (8 mm and 10 mm). No mortality occurred in any procedure. Discussion Stent implantation is a new technique to treat residual stenosis of PA in congenital heart disease.6 This technique can be applied percutaneously for patients with long or multiple sequential stenoses.? Intraoperative implantation can also be used in smaller children and in patients who have limited percutaneous access.3 The stents can also be applied in cases with significant vascular obstructive lesions in the immediate postoperative period, thus avoiding early reoperation in profoundly compromised children.8 Stents have been implanted at different sites in children with congenital heart diseases. Apart from the PA and main branches,6,9 stents have been successfully implanted after atrio-pulmonary and cavo-pulmonary anastomoses, aortic coarctations, and congenital pulmonary vein stenosis.7 Patients with pulmonary atresia may also benefit from stenting after catheter perforation of the atresia by radiofrequency.io,11 Postoperative narrowing of a Fontan anastomosis has also been treated by stenting.12 Table 3. Hemodynamic changes before and after steming. Joumalofthe Saudi Heart Association. Vol. 9, No.1, 1997

10 ARAB ET AL Our data demonstrate that P A stenting can provide effective relief of residual obstructions after surgical correction. The procedure was safe in our cases with no mortality. The immediate results are satisfactory, with a significant decrease of the gradient and R V pressure and an increase in the diameter of the stenotic lesion. Successful implantation of stents was achieved in ten of twelve procedures (83.33%) or in fourteen of the seventeen stents implanted (82.35%). Failure or unsuccessful implantation was encountered in 17.65% of our cases (twice due to migration and once due to failure to implant). Repeat catheterization showed that all stents remained patent in all cases, with only one vessel requiring restenting and three requiring redilating of the stent. These data are consistent with previous reports. Ing et al9 reported a 97% patency rate at follow-up of stented P A and a 94% success rate in repeat dilatation and restenting of these vessels. Mendelsohn et al,3 however, reported restenosis occurrence within stents that have been applied to congenital pulmonary vein stenosis in two of three patients. We conclude that this study demonstrates the efficacy and safety of stent implantation after surgical correction of pulmonary arterial lesions. Besides facilitating corrective surgery when performed before surgery, stent implantation also negates the need for further surgery for residual lesions. Thus, surgery is not always a final therapy. References I. Arbenz U. Interventional catheter therapy in childhood. J Suisse de Medecine 1993; 123(43):2046-55. 2. Radtke W A. Interventional pediatric cardiology: state-of-the art and future perspective. Eur J Pediatr 1994;153(8):542-7. 3. Mendelsohn AM, Bove EL, Lupinetti FM, et al. Intraoperative and percutaneous stenting of congenital pulmonary artery and vein stenosis. Circulation 1993;88(5 PI 2):11210-7. 4. O'Laughlin MP, Perry SB, Lock JE, Mullins CEo Use of endovascular stents in congenital heart disease. Circulation 1991;83(6): 1923-39. 5. Hosking MC, Benson LN, Nakanishi T, et al. Intravascular stent prosthesis for right ventricular outflow obstruction. J Am Coli Cardiol 1992;20(2):373-80. 6. van Oort AM, Tanke RB. Dyen WJ, et al. Endovascular stent in the treatment of residual pulmonary stenosis in patients operated on for congenital heart defects: initial results. Ned Tijdsch Geneeskd 1995; 139(23): 1182-7. 7. Redington AN, Weil J, Somerville J. Self-expanding stents in congenital heart disease. Br Heart J 1994;72(4):378-83. 8. Hatai Y, Nykanen 00, Williams WG, et al. The clinical impact of percutaneous balloon expandable endovascular stents in the management of early postoperative vascular obstruction. Cardiol Young 1996;6:48-53. 9. Ing FF, Grifka RG, Nihill MR, Mullins CEo Repeat dilation of intravascular stents in congenital heart defects. Circulation 1995;92(4):893-7. 10. Hausdorf G, Schneider M, Schirmer KR, et al. Interventional high frequency perforation and enlargement of the outflow tract of pulmonary atresia. Z Kardiol 1993;82(2): 123-30. II. Rosenthal E, Qureshi SA, Tynan M. Non-surgical reconstruction of the right ventricular outflow tract in acquired infundibular atresia. Cardiol Young 1995;5:78-81. 12. O'Laughlin MP, Slack MC, Grifka RG, et al. Implantation and intermediate-term follow-up of stents in congenital heart disease. Circulation 1993;88(2):605-14. Journal of the Saudi Hcan Association. Vol. 9. No. I. 1997